EE05211B1 - Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks - Google Patents

Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks

Info

Publication number
EE05211B1
EE05211B1 EEP200100553A EEP200100553A EE05211B1 EE 05211 B1 EE05211 B1 EE 05211B1 EE P200100553 A EEP200100553 A EE P200100553A EE P200100553 A EEP200100553 A EE P200100553A EE 05211 B1 EE05211 B1 EE 05211B1
Authority
EE
Estonia
Prior art keywords
disorders
saredutant
prevention
preparation
treatment
Prior art date
Application number
EEP200100553A
Other languages
English (en)
Estonian (et)
Inventor
Emonds-Alt Xavier
Soubrie Philippe
Steinberg R�gis
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200100553A publication Critical patent/EE200100553A/xx
Publication of EE05211B1 publication Critical patent/EE05211B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
EEP200100553A 1999-04-27 2000-04-25 Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks EE05211B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905338A FR2792835B3 (fr) 1999-04-27 1999-04-27 Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
PCT/FR2000/001084 WO2000064423A2 (fr) 1999-04-27 2000-04-25 Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression

Publications (2)

Publication Number Publication Date
EE200100553A EE200100553A (et) 2003-02-17
EE05211B1 true EE05211B1 (et) 2009-10-15

Family

ID=9544931

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100553A EE05211B1 (et) 1999-04-27 2000-04-25 Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks

Country Status (33)

Country Link
US (3) US6573281B1 (cs)
EP (1) EP1173179B1 (cs)
JP (1) JP2002542281A (cs)
KR (1) KR20020001850A (cs)
CN (1) CN1172669C (cs)
AR (1) AR023597A1 (cs)
AT (1) ATE234617T1 (cs)
AU (1) AU764304B2 (cs)
BG (1) BG65472B1 (cs)
BR (1) BR0010006A (cs)
CA (1) CA2370834C (cs)
CZ (1) CZ294904B6 (cs)
DE (1) DE60001725T2 (cs)
DK (1) DK1173179T3 (cs)
EE (1) EE05211B1 (cs)
ES (1) ES2193065T3 (cs)
FR (1) FR2792835B3 (cs)
HK (1) HK1041821A1 (cs)
HU (1) HUP0200969A3 (cs)
IL (1) IL145269A0 (cs)
MX (1) MXPA01010904A (cs)
NO (1) NO20015228L (cs)
NZ (1) NZ513851A (cs)
PL (1) PL196479B1 (cs)
PT (1) PT1173179E (cs)
RU (1) RU2238726C2 (cs)
SI (1) SI1173179T1 (cs)
SK (1) SK285459B6 (cs)
TR (1) TR200102512T2 (cs)
TW (1) TWI225399B (cs)
UA (1) UA69441C2 (cs)
WO (1) WO2000064423A2 (cs)
ZA (1) ZA200107143B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
US6846814B2 (en) 2000-04-06 2005-01-25 Astra Zeneca Ab Neurokinin antagonists for use as medicaments
ATE400563T1 (de) * 2000-04-06 2008-07-15 Astrazeneca Ab Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DE60114597T2 (de) * 2000-04-06 2006-07-20 Astrazeneca Ab Naphthamid-neurokinin antagonisten zur verwendung als medikamente
US6903092B2 (en) 2000-04-06 2005-06-07 Peter Bernstein Naphthamide neurokinin antagonists for use as medicaments
GB0019008D0 (en) 2000-08-04 2000-09-27 Astrazeneca Ab Therapeutic compounds
SE0003476D0 (sv) * 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
FR2904221B1 (fr) * 2006-07-31 2008-09-12 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et la fluoxetine.
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
FR2912058A1 (fr) * 2007-02-07 2008-08-08 Sanofi Aventis Sa Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
ATE549316T1 (de) * 2007-09-14 2012-03-15 Hoffmann La Roche Piperidinderivate als nk3-rezeptorantagonisten
US20090076083A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched saredutant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2695626B1 (fr) * 1992-09-17 1994-12-02 Lebroch Yannick Dispositif de gobelet adaptable sur un conteneur de boisson.
FR2700472B1 (fr) 1993-01-19 1995-02-17 Rhone Poulenc Rorer Sa Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2.
US5512680A (en) * 1993-02-26 1996-04-30 Sanofi Process for the preparation of an optically pure aminoalcohol
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
US5554644A (en) * 1994-06-08 1996-09-10 Warner-Lambert Company Tachykinin (NK2) antagonists
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression

Also Published As

Publication number Publication date
EE200100553A (et) 2003-02-17
CZ20013812A3 (cs) 2002-02-13
US20030176462A1 (en) 2003-09-18
US6573281B1 (en) 2003-06-03
FR2792835B3 (fr) 2001-05-25
IL145269A0 (en) 2002-06-30
DK1173179T3 (da) 2003-07-14
UA69441C2 (uk) 2004-09-15
DE60001725T2 (de) 2004-02-05
CZ294904B6 (cs) 2005-04-13
HK1041821A1 (en) 2002-07-26
JP2002542281A (ja) 2002-12-10
FR2792835A1 (fr) 2000-11-03
NO20015228L (no) 2001-12-21
EP1173179B1 (fr) 2003-03-19
CA2370834C (en) 2007-09-25
TR200102512T2 (tr) 2002-04-22
TWI225399B (en) 2004-12-21
CN1348371A (zh) 2002-05-08
PL196479B1 (pl) 2008-01-31
ZA200107143B (en) 2002-10-30
AU4303400A (en) 2000-11-10
AU764304B2 (en) 2003-08-14
CN1172669C (zh) 2004-10-27
MXPA01010904A (es) 2002-06-21
BR0010006A (pt) 2002-01-15
ES2193065T3 (es) 2003-11-01
HUP0200969A2 (hu) 2002-07-29
EP1173179A2 (fr) 2002-01-23
NO20015228D0 (no) 2001-10-25
HUP0200969A3 (en) 2004-03-01
PL351922A1 (en) 2003-06-30
CA2370834A1 (en) 2000-11-02
DE60001725D1 (de) 2003-04-24
SK15472001A3 (sk) 2002-03-05
SI1173179T1 (en) 2003-06-30
NZ513851A (en) 2003-04-29
BG105962A (en) 2002-05-31
ATE234617T1 (de) 2003-04-15
WO2000064423A2 (fr) 2000-11-02
RU2238726C2 (ru) 2004-10-27
US7390823B2 (en) 2008-06-24
KR20020001850A (ko) 2002-01-09
PT1173179E (pt) 2003-06-30
BG65472B1 (bg) 2008-09-30
AR023597A1 (es) 2002-09-04
SK285459B6 (sk) 2007-02-01
WO2000064423A3 (fr) 2001-04-19
US20080227818A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
DE60020613D1 (de) (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
HK1045302A1 (en) Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders.
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
RU2001124802A (ru) Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных средств, применяемых для лечения или предупреждения расстройств настроения, расстройств адаптации или смешанных тревожно-депрессивных расстройств
IL160474A0 (en) Combination products of 1,4-benzothiepine 1,1-dioxide derivatives with other active ingredients and the use thereof
BR9708109A (pt) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinametanol no tratamento de distúrbios depressivos e distúrbios bipolares
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
HUP0200679A2 (en) Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
ZA983753B (en) Medicinal composition for treatment of burns, cuts and like wounds.
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110425